Treatment guidelines lacking for molluscum contagiosum in HIV-positive

Treatment guidelines lacking for molluscum contagiosum in HIV+

(HealthDay)—High-quality studies are lacking in assessing interventions for molluscum contagiosum (MC) in HIV-positive patients, according to a review published online March 18 in the International Journal of Dermatology.

Paul Martin, B.M.B.S., from the London School of Hygiene and Tropical Medicine, conducted a systematic literature review in order to assess strategies for treating MC in people concomitantly infected with HIV and develop recommendations on best management strategies for these patients.

Based on 13 studies reviewed, Martin found that the quality of study design was poor. Additionally, there was a wide array of outcome variables and a lack of objective evidence. This prevented the development of specific recommendations for the treatment of MC in HIV-positive patients.

"Despite the good impact antiretroviral therapy has made on prevalence of dermatologic disease, MC remains an important cause of morbidity in HIV-positive populations," Martin writes "Well-designed, adequately powered, randomized, controlled studies are very much needed to provide an evidence base to aid clinical decision making."

Explore further

More than two million people co-infected with HIV and hepatitis C

More information: Abstract
Full Text (subscription or payment may be required)

Copyright © 2016 HealthDay. All rights reserved.

Citation: Treatment guidelines lacking for molluscum contagiosum in HIV-positive (2016, April 4) retrieved 15 August 2022 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors